1. Home
  2. SOL vs ACOG Comparison

SOL vs ACOG Comparison

Compare SOL & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Emeren Group Ltd each representing 10 shares

SOL

Emeren Group Ltd each representing 10 shares

HOLD

Current Price

$1.94

Market Cap

98.5M

Sector

Technology

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$5.46

Market Cap

115.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SOL
ACOG
Founded
2005
2000
Country
United States
Canada
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
98.5M
115.5M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
SOL
ACOG
Price
$1.94
$5.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$4.50
$18.00
AVG Volume (30 Days)
270.2K
79.3K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$71,226,000.00
$7,427,199.00
Revenue This Year
N/A
N/A
Revenue Next Year
$45.37
$143.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$3.75
52 Week High
$2.30
$11.54

Technical Indicators

Market Signals
Indicator
SOL
ACOG
Relative Strength Index (RSI) 68.41 41.95
Support Level $1.89 $4.99
Resistance Level $1.95 $6.74
Average True Range (ATR) 0.05 0.47
MACD 0.02 -0.04
Stochastic Oscillator 96.54 27.43

Price Performance

Historical Comparison
SOL
ACOG

About SOL Emeren Group Ltd each representing 10 shares

Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: